据美国证券交易委员会(SEC)文件显示,Lisata Therapeutics于8月3日批准了一项大规模裁员计划。该计划将裁减约72%的员工,且自批准之日起立即生效。这一削减力度极为显著,涉及公司内部多个岗位。目前,公司并未透露此次裁员的具体原因及后续补偿方案。
据美国证券交易委员会(SEC)文件显示,Lisata Therapeutics于8月3日批准了一项大规模裁员计划。该计划将裁减约72%的员工,且自批准之日起立即生效。这一削减力度极为显著,涉及公司内部多个岗位。目前,公司并未透露此次裁员的具体原因及后续补偿方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.